CJC-1295 with DAC vs Ipamorelin
Compare CJC-1295 with DAC (a GHRH analog) and Ipamorelin (a ghrelin mimetic), two popular growth hormone secretagogues that work through entirely different receptor pathways.
CJC1295 with DAC
Growth Hormone / GH Secretagogues
Ipamorelin
Growth Hormone / GH Secretagogues
Side-by-Side Comparison
Synthetic GHRH analog with Drug Affinity Complex (DAC) that covalently binds to serum albumin, stimulating sustained GH release from pituitary somatotrophs via GHRH receptors
Highly selective growth hormone secretagogue that acts on ghrelin/GHS receptor (GHSR) in the pituitary to stimulate pulsatile GH release without affecting cortisol or prolactin
GHRH receptor on pituitary somatotrophs
Ghrelin/GHS receptor (GHSR-1a)
~6-8 days (due to albumin binding via DAC)
~2 hours
Typically studied 1-2x per week
Typically studied 2-3x daily
\u226599% (HPLC verified at 99.6%)
\u226599% (HPLC verified at 99.7%)
Sustained GH elevation, extended GHRH receptor pharmacology, albumin-binding drug delivery, GH axis modulation, body composition and muscle growth
Selective GH secretion without cortisol elevation, synergistic combination with GHRH analogs, bone density studies, body composition and recovery, GH axis selectivity
3647.25 Da
711.85 Da
$24.95/vial (2mg)
$6.95/vial (2mg)
Synthetic GHRH analog with Drug Affinity Complex (DAC) that covalently binds to serum albumin, stimulating sustained GH release from pituitary somatotrophs via GHRH receptors
Highly selective growth hormone secretagogue that acts on ghrelin/GHS receptor (GHSR) in the pituitary to stimulate pulsatile GH release without affecting cortisol or prolactin
GHRH receptor on pituitary somatotrophs
Ghrelin/GHS receptor (GHSR-1a)
~6-8 days (due to albumin binding via DAC)
~2 hours
Typically studied 1-2x per week
Typically studied 2-3x daily
\u226599% (HPLC verified at 99.6%)
\u226599% (HPLC verified at 99.7%)
Sustained GH elevation, extended GHRH receptor pharmacology, albumin-binding drug delivery, GH axis modulation, body composition and muscle growth
Selective GH secretion without cortisol elevation, synergistic combination with GHRH analogs, bone density studies, body composition and recovery, GH axis selectivity
3647.25 Da
711.85 Da
$24.95/vial (2mg)
$6.95/vial (2mg)
Detailed Breakdown
Mechanism
Synthetic GHRH analog with Drug Affinity Complex (DAC) that covalently binds to serum albumin, stimulating sustained GH release from pituitary somatotrophs via GHRH receptors
Highly selective growth hormone secretagogue that acts on ghrelin/GHS receptor (GHSR) in the pituitary to stimulate pulsatile GH release without affecting cortisol or prolactin
Receptor Targets
GHRH receptor on pituitary somatotrophs
Ghrelin/GHS receptor (GHSR-1a)
Half-Life
~6-8 days (due to albumin binding via DAC)
~2 hours
Dosing Frequency
Typically studied 1-2x per week
Typically studied 2-3x daily
Purity
\u226599% (HPLC verified at 99.6%)
\u226599% (HPLC verified at 99.7%)
Research Applications
Sustained GH elevation, extended GHRH receptor pharmacology, albumin-binding drug delivery, GH axis modulation, body composition and muscle growth
Selective GH secretion without cortisol elevation, synergistic combination with GHRH analogs, bone density studies, body composition and recovery, GH axis selectivity
Molecular Weight
3647.25 Da
711.85 Da
Starting Price
$24.95/vial (2mg)
$6.95/vial (2mg)
Which Is Right for Your Research?
Choose CJC-1295 with DAC for sustained, continuous GH elevation via GHRH receptor stimulation. Choose Ipamorelin for selective, pulsatile GH release via the ghrelin receptor without cortisol or prolactin side effects. They are frequently studied together for synergistic GH release.